Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Lu‐Nan Qi"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Several inflammatory indicators have been reported to have predictive value in many types of malignant cancer. This research was aimed to explore the ability of the monocyte-to-lymphocyte ratio (MLR) to predict prognosis in patien
Externí odkaz:
https://doaj.org/article/6d5ef808ea654912bd8f3a7ab9884609
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15065-15078 (2023)
Abstract Background and Aims Extrahepatic recurrence (EHR) is one of the major reasons for the poor prognosis of hepatocellular carcinoma (HCC). The present study aimed to develop and assess the performance of predictive models by using a combination
Externí odkaz:
https://doaj.org/article/2073caa4bc724cc89f4404e731ae9b77
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractBackground We aimed to assess differences in intestinal microflora between patients with operable hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) with microvascular invasion (MVI) and those without MVI. Additionally, we investiga
Externí odkaz:
https://doaj.org/article/0b892a3f1c9e40b49a69f4d258ee0571
Publikováno v:
Annals of Medicine, Vol 55, Iss 1 (2023)
AbstractPurpose The purpose of this study was to estimate the clinical efficacy and identify the best beneficiaries of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in hepatocellular carcinoma (HCC).Patients and methods A
Externí odkaz:
https://doaj.org/article/e299cf7fe5424e118d986037b4750d4c
Autor:
Rong-Rui Huo, Hao-Tian Liu, Zhu-Jian Deng, Xiu-Mei Liang, Wen-Feng Gong, Lu-Nan Qi, Xue-Mei You, Bang-De Xiang, Le-Qun Li, Liang Ma, Jian-Hong Zhong
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundThe relationship between serum prealbumin and the risk of all-cause mortality after hepatectomy in patients with hepatocellular carcinoma (HCC) needs to be evaluated.MethodsWe conducted a retrospective study. A Cox proportional hazards regr
Externí odkaz:
https://doaj.org/article/d9d96e0912bc4c6793fc124e9eb169b2
Autor:
Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear. Methods Between August 2004 and November 2014, 104 patients w
Externí odkaz:
https://doaj.org/article/7758fe4134b04e4f87b37ea60b59bbdb
Autor:
Lu-Nan Qi, Le-Qun Li, Yuan-Yuan Chen, Zhao-Hong Chen, Tao Bai, Bang-De Xiang, Xiao Qin, Kai-Yin Xiao, Min-Hao Peng, Zhi-Ming Liu, Tang-Wei Liu, Xue Qin, Shan Li, Ze-Guang Han, Zeng-Nan Mo, Regina M Santella, Cheryl A Winkler, Stephen J O'Brien, Tao Peng
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83465 (2013)
Both hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure can cause liver damage as well as increase the probability of hepatocellular carcinoma (HCC). To investigate the underlying genetic changes that may influence development of HCC associated
Externí odkaz:
https://doaj.org/article/f13bf4d62ef6439c86d598b2dafbacf0
Publikováno v:
Clinical Science. 137:303-316
Background: Postoperative transarterial chemoembolization (PA-TACE) is an effective adjuvant therapy for preventing early postoperative recurrence of hepatocellular carcinoma (HCC); however, many patients are insensitive to it. Therefore, the present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb29a64ca14848e85d48813342ec453b
https://doi.org/10.1042/cs20220661
https://doi.org/10.1042/cs20220661
Autor:
Lu‐Nan Qi, Liang Ma, Fei‐Xiang Wu, Yuan‐Yuan Chen, Jing‐Xuan Xu, Yu‐Chong Peng, Zu‐Shun Chen, Wen‐Feng Gong, Cheng‐Lei Yang, Hao‐Wen Wei, Shui‐Ling Qin, Jin‐Jie Shang, Qiu‐Yan Wang, Hong‐Ping Yu, Tao Peng, Ying‐Wu Huang, Yong‐Chi Ling, Wei‐Zhong Tang, Bang‐De Xiang, Le‐Qun Li
Publikováno v:
Liver International. 42:2283-2298
The multiplicity of hepatocellular carcinoma (HCC) recurrence patterns is the most important determinant of patients' postsurgical survival. A systematic HCC recurrence classification is needed to help prevent and treat postoperative HCC recurrence i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d9f8fb76c5552f673d9a461ed4fc981
https://doi.org/10.1111/liv.15363
https://doi.org/10.1111/liv.15363
Autor:
Hang-Hang Ni, Xi-Hua Yang, Cheng-Lei Yang, Qian Zhang, Jing-Xuan Xu, Lu-Nan Qi, Bang-De Xiang
Publikováno v:
BioMed Research International. 2022:1-9
Background. Both the preoperative neutrophil-lymphocyte ratio (NLR) and circulating tumor cell count (CTC) are associated with poor prognosis in hepatocellular carcinoma (HCC). The purpose of this study was to explore the prognostic value of these tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cd67078da7ef6cd49779a32af7ce86
https://doi.org/10.1155/2022/7305953
https://doi.org/10.1155/2022/7305953